Cellular distribution of angiotensin-converting enzyme after myocardial infarction

M Falkenhahn1, F Franke, R M Bohle

  • 1Department of Pharmacology, University of Kiel, Germany.

Insights

Angiotensin-converting enzyme (ACE) is mainly found in endothelial cells and macrophages after heart attack. Its increased presence during fibrosis suggests a key role in cardiac repair and remodeling.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Tissue Repair Mechanisms

Background:

  • Angiotensin-converting enzyme (ACE) plays a critical role in cardiovascular regulation.
  • Understanding ACE cellular localization is crucial for studying cardiac remodeling post-myocardial infarction.
  • Left ventricular repair involves complex cellular interactions and molecular signaling.

Purpose of the Study:

  • To investigate the cellular distribution of ACE in the heart before and after myocardial infarction.
  • To identify cell types involved in left ventricular repair and remodeling that express ACE.
  • To elucidate the role of ACE in the context of cardiac fibrosis and tissue repair.

Main Methods:

  • Immunohistochemical techniques using monoclonal and polyclonal antibodies.
  • Analysis of human and rat myocardial tissue samples.
  • In situ hybridization for collagen type I in a rat myocardial infarction model.

Main Results:

  • In noninfarcted hearts, ACE was primarily in endothelial cells and aortic valve subendocardial layers.
  • Post-myocardial infarction, ACE expression was induced in capillary endothelial cells and macrophages at the infarct margin.
  • Intense ACE staining was observed in the fibrotic repair zone, inversely correlated with collagen type I expression.
  • Vascular smooth muscle cells and cardiomyocytes showed no ACE expression.

Conclusions:

  • Endothelial cells are the primary source of ACE expression following myocardial infarction.
  • ACE induction during fibrosis suggests a significant role in cardiac tissue repair and remodeling.
  • ACE localization patterns provide insights into the molecular mechanisms of post-infarction cardiac healing.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...